Skip to main content

Table 3 MSC-derived secretome (e.g., exosome) therapy in preclinical models of common neurodegenerative diseases

From: Therapeutic utility of mesenchymal stromal cell (MSC)-based approaches in chronic neurodegeneration: a glimpse into underlying mechanisms, current status, and prospects

Condition

Model

Cell source

Administration route

Results

Ref.

AD

3xTg mice

BM

Intranasal

Induction of neuroprotection by provoking anti-inflammatory effect

[92]

AD

APP/PS1 mice

BM

Intravenous

Amelioration in learning and memory capabilities, reducing Aβ levels and supporting anti-inflammatory environment

[217]

AD

APP/PS1 mice

BM

Intravenous

Cognitive impairment rescue by improving microRNA-146a levels in the hippocampus

[105]

AD

Aluminum chloride-injected rat

BM

Intravenous

Pathological symptoms rescue

[218]

PD

6-OHDA rat

BM

Intravenous

Attenuation of dopaminergic neuron loss in SN, and improving dopamine levels in the striatum

[93]

PD

6-OHDA rat

BM

Intravenous

Neuroprotective effect on dopaminergic neuron

[219]

PD

MPTP mice

AT

Intravenous

Suppression of autophagy and pyroptosis

[155]

PD

MPTP mice

AT

Intraperitoneal

Promotion of the angiogenesis of human brain microvascular endothelial cells (HBMECs)

[95]

PD

6-OHDA rat

AT

NA

Induction of neuroprotection by upregulation of the sirtuin 3 (SIRT3) levels

[220]

PD

6-OHDA rat

BM

Intravenous

Improving motor function

[221]

PD

6-OHDA rat

BM

Intranigral

Intrastriatal

Reverting motor phenotype and the neuronal organization

[222]

PD

α-Syn induced C. elegans

BM

NA

Reduced number of α-syn inclusions

[153]

HD

R6/2 mice

AM

Intraperitoneal

Amelioration of neurological complications rotarod function

[162]

ALS

SOD1G93A mice

AT

Intravenous

Intranasal

Inhibition of glial cells activation, supporting motor neuron rescue, and protecting the neuromuscular junction

[161]

  1. MSCs, mesenchymal stromal cells; AD, Alzheimer’s disease; PD, Parkinson’s disease; ALS, amyotrophic lateral sclerosis; HD, Huntington’s disease; BM, bone marrow; 6-OHDA, 6-hydroxydopamine; MPTP, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Aβ, amyloid beta peptide; AM, amniotic membrane